User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.

Takaori K, Iwatani H, Yamato M, Ito T

Open source

DOI
10.1186/s12882-020-02198-6
Published
2021 Jan 6
Container
BMC nephrology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12882-020-02198-6,
  title = {User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.},
  author = {Takaori K and Iwatani H and Yamato M and Ito T},
  year = {2021},
  journal = {BMC nephrology},
  doi = {10.1186/s12882-020-02198-6},
  url = {https://doi.org/10.1186/s12882-020-02198-6}
}

RIS

TY  - JOUR
TI  - User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.
AU  - Takaori K
AU  - Iwatani H
AU  - Yamato M
AU  - Ito T
PY  - 2021
JO  - BMC nephrology
DO  - 10.1186/s12882-020-02198-6
UR  - https://doi.org/10.1186/s12882-020-02198-6
ER  - 

APA

K, T., H, I., M, Y., & T, I. (2021). User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.. BMC nephrology. https://doi.org/10.1186/s12882-020-02198-6

Source records